- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT06689800
Vamos cair na real: ferramenta de comunicação de saúde familiar em transplante de células-tronco pediátricas e terapia celular
Vamos cair na real: um teste piloto de uma ferramenta de comunicação de saúde familiar em transplante pediátrico de células-tronco e terapia celular
The investigators will conduct a pilot feasibility and efficacy trial of a newly developed family health communication tool (called Let's Get REAL) in increasing youth involvement in real-time stem cell transplant and cellular therapy decisions (SCTCT). The investigators will pilot the intervention among 24 youth and their parents, stratified by youth age (stratum 1, 8-12 years of age and stratum 2, 13-17 years of age).
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Ginny L Schulz, Ph.D., RN, CPNP-PC
- Número de telefone: 314-454-6018
- E-mail: schulz_g@wustl.edu
Locais de estudo
-
-
Missouri
-
St Louis, Missouri, Estados Unidos, 63110
- Recrutamento
- Washington University School of Medicine
-
Subinvestigador:
- Shalini Shenoy, M.D.
-
Contato:
- Ginny L Schulz, Ph.D., RN, CPNP-PC
- Número de telefone: 314-454-6018
- E-mail: schulz_g@wustl.edu
-
Investigador principal:
- Ginny L Schulz, Ph.D., RN, CPNP-PC
-
Subinvestigador:
- Amy McQueen, Ph.D.
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria Youth:
- Children or adolescents 8-17 years of age referred for SCTCT.
- Diagnosis of malignant or nonmalignant disorder.
- Referred for any type of SCTCT. Autologous and allogeneic stem cell and cellular therapies are eligible.
- Planning to meet with a provider to discuss SCTCT.
- Must have the ability to understand and willingness to consent to participate after reviewing an IRB approved informed assent document.
- Must speak English and be cognitively able to participate.
Inclusion Criteria Parents:
- Parent or guardian of a child 8-17 years of age with any diagnosis referred for any type of SCTCT. Diagnoses may include malignant and nonmalignant disorders. Autologous and allogeneic stem cell and cellular therapies are eligible. Parent or guardian is defined as an adult who usually cares for the youth and has authority to make medical decisions for them.
- Must have the ability to understand and willingness to consent to participate after reviewing an IRB approved informed consent document.
- Must speak English and be cognitively able to participate.
Exclusion Criteria Youth:
-
Active medical problems severe enough to preclude study participation at the time of recruitment.
- Patients who are otherwise eligible, but whose primary transplant physician does not want them to participate in the study.
-
Lacks cognitive capacity to complete study activities, as determined by consenting professional.
Exclusion Criteria Parents:
- Their youth referred for SCTCT does not assent to participate.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Pesquisa de serviços de saúde
- Alocação: Não randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Let's Get REAL family health communication tool: Patients (8-12 years of age)
Patients and parent(s) will be given the Let's Get REAL family health communication tool to use up to one month prior to their SCTCT consultation visit. It is a guide for pediatric patients and their families to learn about and discuss SCTCT. Participants will complete demographic and baseline surveys prior to using the tool, and then additional surveys up to one month after SCTCT consultation visit and up to one month post-discharge from SCTCT. SCTCT consultation visits will be audio-recorded. Participants may also participate in an optional semi-structured interview up to 8 weeks after SCTCT consultation. |
Family health communication tool |
|
Experimental: Let's Get REAL family health communication tool: Patients (13-17 years of age)
Patients and parent(s) will be given the Let's Get REAL family health communication tool to use up to one month prior to their SCTCT consultation visit. It is a guide for pediatric patients and their families to learn about and discuss SCTCT. Participants will complete demographic and baseline surveys prior to using the tool, and then additional surveys up to one month after SCTCT consultation visit and up to one month post-discharge from SCTCT. SCTCT consultation visits will be audio-recorded. Participants may also participate in an optional semi-structured interview up to 8 weeks after SCTCT consultation. |
Family health communication tool |
|
Experimental: Let's Get REAL family health communication tool: Parents
Patients and parent(s) will be given the Let's Get REAL family health communication tool to use up to one month prior to their SCTCT consultation visit. It is a guide for pediatric patients and their families to learn about and discuss SCTCT. Participants will complete demographic and baseline surveys prior to using the tool, and then additional surveys up to one month after SCTCT consultation visit and up to one month post-discharge from SCTCT. SCTCT consultation visits will be audio-recorded. Participants may also participate in an optional semi-structured interview up to 8 weeks after SCTCT consultation. |
Family health communication tool |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Feasibility of intervention as measured by the Feasibility of Intervention questionnaire
Prazo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a 4-item scale that youth and their parents report feasibility of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater feasibility. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Acceptability of intervention as measured by the Acceptability of Intervention questionnaire
Prazo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a 4-item scale that youth and their parents report acceptability of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater acceptability. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Appropriateness of intervention as measured by the Intervention of Appropriateness questionnaire
Prazo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a 4-item scale that youth and their parents report appropriateness of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater appropriateness. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Feasibility of intervention as measured qualitatively
Prazo: Up to 8 weeks after SCTCT consultation (estimated to be week 16)
|
Content analysis of open-ended survey responses and quotations from individual interviews. Will be collecting number of feasibility content codes. |
Up to 8 weeks after SCTCT consultation (estimated to be week 16)
|
|
Acceptability of intervention as measured qualitatively
Prazo: Up to 8 weeks after SCTCT consultation (estimated to be week 16)
|
Content analysis of open-ended survey responses and quotations from individual interviews. Will be collecting number of acceptability content codes. |
Up to 8 weeks after SCTCT consultation (estimated to be week 16)
|
|
Appropriateness of intervention as measured qualitatively
Prazo: Up to 8 weeks after SCTCT consultation (estimated to be week 16)
|
Content analysis of open-ended survey responses and quotations from individual interviews. Will be collecting number of appropriateness content codes. |
Up to 8 weeks after SCTCT consultation (estimated to be week 16)
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Número de pacientes que escolheram SCTCT
Prazo: Até 4 semanas após a consulta SCTCT (estimada na semana 8)
|
Até 4 semanas após a consulta SCTCT (estimada na semana 8)
|
|
|
Difference in feasibility scores in those 8-12 years of age and those 13-17 years of age as measured by the Feasibility of Intervention questionnaire
Prazo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a 4-item scale that youth and their parents report feasibility of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater feasibility. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Difference in acceptability scores in those 8-12 years of age and those 13-17 years of age as measured by the Acceptability of Intervention questionnaire
Prazo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a 4-item scale that youth and their parents report acceptability of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater acceptability. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Difference in appropriateness scores in those 8-12 years of age and those 13-17 years of age as measured by the Intervention of Appropriateness questionnaire
Prazo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a 4-item scale that youth and their parents report appropriateness of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater appropriateness. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Perceived levels of decision-making involvement in youth 8-17 years of age and their parents as measured by the Decision Making Involvement Scale
Prazo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a 30-item scale that youth and their parents report youth involvement behaviors in a decision related to their illness on a 4-point Likert scale ranging from 'A Little Bit' to 'A Lot'. The higher the subscale score (child seek, child express, parent seek, parent express, and joint/options), the more that behavior or type of involvement occurred in the decision making process. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Observed levels of decision-making involvement in youth 8-17 years of age and their parents
Prazo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
Number of utterance occurrences for the following: 1) who uttered (youth, parent), 2) was utterance prompted (yes/no), if so, by who, 3) type of utterance (questions, opinion, concern, other), and 4) content of utterance (prognosis, side effect, expectation). |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Change in youth-parent communication as measured by the Likert-type Parent-Adolescent Communication Scale
Prazo: Up to 4 weeks prior to SCTCT consultation and up to 4 weeks after SCTCT consultation (estimated to be 8 weeks)
|
This is a 20-item scale that youth and parents report the degree of openness in family communication and the extent of problems with family communications on a 5-point Likert ranging from 'strongly disagree' to 'strongly agree'. A higher score on the degree of openness subscale indicates better communication between parent and adolescent. For extent of problems subscale, a higher score indicates more problems in the parent-child communication. |
Up to 4 weeks prior to SCTCT consultation and up to 4 weeks after SCTCT consultation (estimated to be 8 weeks)
|
|
Change in the level of youth's general anxiety as measured by the Likert-type PROMIS Anxiety 8a Short Form or parent proxy
Prazo: Up to 4 weeks prior to SCTCT consultation and up to 4 weeks after SCTCT consultation (estimated to be 8 weeks)
|
This is an 8-item scale that measures youth's general anxiety in those 8-17 years of age on a 5-point Likert scale ranging from 'never' to 'almost always'. |
Up to 4 weeks prior to SCTCT consultation and up to 4 weeks after SCTCT consultation (estimated to be 8 weeks)
|
|
Level of decisional conflict as measured by the Likert-type Decisional Conflict Scale
Prazo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a 10-item scale that youth and parents report their personal uncertainty and decisional conflict related to a specific decision. We are using the question format as it is recommended for those with limited reading or response skills. They respond 'Yes', 'No, or 'Unsure'. A total decision conflict score ranges from 0 (no decisional conflict) to 100 (extremely high decision conflict). Higher scores on subscales uncertainty, informed, values clarity, and support reflect feeling extremely uncertain about the best choice, feeling extremely uninformed, feeling extremely unclear about personal values, and feeling extremely unsupported in decision making respectively. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Youth-parent congruence of youth decision making involvement as measured by two Likert type statements
Prazo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
Number of dyads that agree on these two statements measured on a 4-point Likert scale ranging from 'Not at all' to 'A lot': 1)"I/my child should be involved in future talks about transplant" and 2) "I/my child wants to be involved in future talks about transplant". |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Satisfaction with the decision making involvement as measured by one Likert type statement
Prazo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a one item statement, "I am satisfied with my/my child's involvement in the transplant decision making process", measured on a 4-point Likert scale ranging from 'Not at all' to 'A lot'. A higher score indicates more satisfaction. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Ginny Schulz, Ph.D., RN, CPNP-PC, Washington University School of Medicine
Publicações e links úteis
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
- Distúrbios de Insuficiência da Medula Óssea
- Neoplasias por local
- Neoplasias
- Doenças Genéticas, Congênitas
- Doenças do sistema imunológico
- Doenças Hematológicas
- Doenças da Medula Óssea
- Anemia Hemolítica Congênita
- Anemia Hemolítica
- Anemia
- Hemoglobinopatias
- Doenças e Anormalidades Congênitas, Hereditárias e Neonatais
- Doenças Nutricionais e Metabólicas
- Doenças hemic e linfáticas
- Neoplasias Hematológicas
- Anemia Falciforme
- Síndromes de Deficiência Imunológica
- Doenças Metabólicas
- Anemia Aplástica
Outros números de identificação do estudo
- 202410119
- K12CA167540 (Concessão/Contrato do NIH dos EUA)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .